Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma

Fig. 3

Mendelian randomization results of causal risk proteins on the risk of multiple myeloma. FDR P-value indicates the P-value was adjusted for multiple testing using false-discovery rate (FDR) method. C1QC, complement C1q subcomponent subunit C; CBR1, carbonyl reductase 1; FCGR3B, Fc-gamma receptor III-B; FSTL1, follistatin-related protein 1; FDR, false discovery rate; GPC1, glypican 1; GZMB, granzyme B; NAMPT, nicotinamide phosphoribosyl transferase; NCF2, neutrophil cytosol factor 2; PAFAH1B2, platelet-activating factor acetyl hydrolase IB subunit beta; PDE4D, cAMP-specific 3',5'-cyclic phosphodiesterase 4D; PTPN4, protein tyrosine phosphatase non-receptor type 4; SOCS3, suppressor of cytokine signaling 3; TIE1, Tyrosine kinase with immunoglobulin-like and EGF-like domains 1; SNP, single nucleotide polymorphism

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us